Job F M van Boven Selected Research

Job F M van Boven Research Topics

25	Chronic Obstructive Pulmonary Disease (COPD) 01/2024 - 08/2014
24	Asthma (Bronchial Asthma) 01/2024 - 08/2014
7	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2018
2	Drug-Related Side Effects and Adverse Reactions 01/2022 - 05/2021
2	Rhinosinusitis 01/2020 - 01/2020
2	Rhinitis 01/2020 - 01/2020
2	Oral Candidiasis (Thrush) 01/2020 - 04/2013
2	Osteoporosis 08/2014 - 09/2013
1	Anaphylaxis (Anaphylactic Shock) 01/2023
1	COVID-19 01/2023
1	Infections 01/2023
1	Neoplasms (Cancer) 01/2023
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023
1	Allergic Rhinitis 11/2022
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 07/2022
1	Hypoglycemia (Reactive Hypoglycemia) 07/2022
1	Sleep Wake Disorders 01/2022
1	Communicable Diseases (Infectious Diseases) 11/2021
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2021
1	Hypertension (High Blood Pressure) 01/2021
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2021
1	Noncommunicable Diseases 01/2021
1	Heart Diseases (Heart Disease) 01/2021
1	Tobacco Use Disorder (Nicotine Dependence) 01/2021
1	Mental Disorders (Mental Disorder) 01/2021
1	Dysphonia (Spastic Dysphonia) 01/2020
1	Respiratory Insufficiency (Respiratory Failure) 01/2020
1	Stroke (Strokes) 07/2014
1	Myocardial Infarction 07/2014
1	Parkinson Disease (Parkinson's Disease) 03/2014

15	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2023 - 04/2013
4	Bronchodilator Agents (Bronchodilators)IBA 01/2021 - 10/2014
3	SteroidsIBA 01/2023 - 01/2020
3	Antihypertensive Agents (Antihypertensives)IBA 01/2021 - 01/2020
2	Varenicline (Chantix)FDA Link 01/2022 - 01/2021
2	LDL CholesterolIBA 01/2022 - 01/2021
2	3- (2- (4- azidobenzamidino)ethyl)- 5- hydroxyindole (SABA)IBA 01/2021 - 10/2018
2	GoldIBA 01/2021 - 10/2019
2	Insulin (Novolin)FDA Link 12/2019 - 01/2018
2	Formoterol Fumarate (Oxis)FDA Link 10/2018 - 10/2014
2	Salmeterol Xinafoate (Serevent)FDA Link 12/2017 - 10/2014
2	indacaterolIBA 12/2017 - 10/2014
1	Biosimilar PharmaceuticalsIBA 10/2023
1	ElementsIBA 10/2023
1	Anaplastic Lymphoma KinaseIBA 01/2023
1	alectinibIBA 01/2023
1	Hypoglycemic Agents (Hypoglycemics)IBA 07/2022
1	Glucose (Dextrose)FDA LinkGeneric 07/2022
1	Omalizumab (Xolair)FDA Link 01/2022
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2022
1	dupilumabIBA 01/2022
1	benralizumabIBA 01/2022
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022
1	reslizumabIBA 01/2022
1	mepolizumabIBA 01/2022
1	SmokeIBA 01/2021
1	Muscarinic AntagonistsIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Particulate MatterIBA 01/2019
1	Budesonide (Pulmicort)FDA LinkGeneric 10/2018
1	Fluticasone (Cutivate)FDA LinkGeneric 12/2017
1	Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric 12/2017
1	Diphosphonates (Bisphosphonates)IBA 08/2014
1	LipidsIBA 08/2014
1	ropinirole (Requip)FDA LinkGeneric 03/2014

18	Nebulizers and Vaporizers (Inhaler) 01/2024 - 10/2014
13	Therapeutics 01/2024 - 04/2013
3	Metered Dose Inhalers (Metered Dose Inhaler) 01/2022 - 04/2017
3	Dry Powder Inhalers 01/2022 - 04/2017
3	Biological Therapy 01/2022 - 01/2018
2	Drug Therapy (Chemotherapy) 09/2022 - 05/2021
1	Patient Care Bundles 10/2023
1	Continuity of Patient Care 10/2023
1	Patient Readmission 10/2023
1	Glycemic Control 07/2022
1	Transplantation 11/2021
1	Nicotine Replacement Therapy 01/2021
1	Noninvasive Ventilation 01/2020
1	Off-Label Use 12/2016
1	Respiratory Therapy (Therapy, Respiratory) 10/2014
1	Secondary Prevention 07/2014